13F-HR filed by Endurant Capital Management LP
Endurant Capital Management LP filed this 13F-HR for the quarter ended 2020-09-30, filed 2020-11-16, with 60 holding rows worth $338,154,000.
- Accession
- 0001633055-20-000005
- Filer
- CIK 1633055
- Filed
- 2020-11-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2020
A holdings report, 60 entries on the cover page, a total value of $338,154,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $338,154,000 with VALUE read as thousands by filing date, 13F file number 028-16634. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPY | 78462F103 | SHS | 91,300 | $30,772,000 | thousands by filing date | put |
| Bristol-Myers Squibb Company | 110122108 | COM | 390,156 | $23,523,000 | thousands by filing date | |
| OXFORD IMMUNOTEC GLOBAL PLC | G6855A103 | ORD SHS | 1,754,465 | $20,527,000 | thousands by filing date | |
| ENCOMPASS HEALTH CORP COM | 29261A100 | Stock | 276,105 | $17,941,000 | thousands by filing date | |
| AbbVie,Inc. | 00287Y109 | COM | 198,921 | $17,423,000 | thousands by filing date | |
| INTEGRA LIFESCIENCES HLDGS C | 457985208 | COM NEW | 281,608 | $13,298,000 | thousands by filing date | |
| iShares Russell 2000 ETF | 464287655 | SHS | 80,500 | $12,058,000 | thousands by filing date | put |
| Cigna Corporation | 125523100 | COM | 67,461 | $11,429,000 | thousands by filing date | |
| ADAPTHEALTH CORP | 00653Q102 | COMMON STOCK | 518,377 | $11,306,000 | thousands by filing date | |
| Johnson & Johnson | 478160104 | COM | 74,979 | $11,163,000 | thousands by filing date | |
| SI BONE INC | 825704109 | COM | 463,150 | $10,986,000 | thousands by filing date | |
| ZOETIS INC CL A | 98978V103 | Stock | 46,960 | $7,766,000 | thousands by filing date | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 54,234 | $7,383,000 | thousands by filing date | |
| CONMED CORP COM | 207410101 | Stock | 81,205 | $6,388,000 | thousands by filing date | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 837,137 | $6,371,000 | thousands by filing date | |
| MCKESSON CORP COM | 58155Q103 | Stock | 40,419 | $6,020,000 | thousands by filing date | |
| SYNEOS HEALTH INC | 87166B102 | CL A | 112,151 | $5,962,000 | thousands by filing date | |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 126,764 | $5,821,000 | thousands by filing date | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 52,000 | $5,794,000 | thousands by filing date | put |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 372,401 | $5,292,000 | thousands by filing date | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 135,901 | $5,051,000 | thousands by filing date | |
| Elevance Health, Inc. | 036752103 | COM | 17,909 | $4,810,000 | thousands by filing date | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 462,170 | $4,645,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 144,313 | $4,638,000 | thousands by filing date | |
| MOLECULAR TEMPLATES INC | 608550109 | COM | 422,787 | $4,617,000 | thousands by filing date | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 574,502 | $4,585,000 | thousands by filing date | |
| MUSTANG BIO INC | 62818Q104 | COM | 1,423,050 | $4,483,000 | thousands by filing date | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 74,408 | $4,340,000 | thousands by filing date | |
| PATTERSON COS INC | 703395103 | COM | 163,415 | $3,939,000 | thousands by filing date | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 1,512,069 | $3,750,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 1,432,817 | $3,682,000 | thousands by filing date | |
| VAPOTHERM INC | 922107107 | COM | 125,675 | $3,645,000 | thousands by filing date | |
| HAEMONETICS CORP MASS COM | 405024100 | Stock | 41,607 | $3,630,000 | thousands by filing date | |
| PETMED EXPRESS INC | 716382106 | COM | 105,895 | $3,348,000 | thousands by filing date | |
| QUEST DIAGNOSTICS INC COM | 74834L100 | Stock | 29,041 | $3,325,000 | thousands by filing date | |
| CALLIDITAS THERAPEUTICS AB SPONSERED | 13124Q106 | ADS | 111,467 | $2,675,000 | thousands by filing date | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 262,773 | $2,625,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 97,374 | $2,453,000 | thousands by filing date | |
| TRANSLATE BIO INC. | 89374L104 | Common Stock | 176,710 | $2,405,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 56,210 | $2,247,000 | thousands by filing date | |
| ALCON AG ORD SHS | H01301128 | Stock | 38,373 | $2,185,000 | thousands by filing date | |
| APTOSE BIOSCIENCES INC COM | 03835T200 | Stock | 345,172 | $2,071,000 | thousands by filing date | |
| IMMUNIC INC | 4525EP101 | COM | 110,911 | $2,060,000 | thousands by filing date | |
| BIO RAD LABS INC | 090572207 | CL A | 3,916 | $2,019,000 | thousands by filing date | |
| FIVE PRIME THERAPEUTICS INC. | 33830X104 | Common Stock | 421,398 | $1,981,000 | thousands by filing date | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 117,480 | $1,800,000 | thousands by filing date | |
| DAVITA INC COM | 23918K108 | Stock | 21,002 | $1,799,000 | thousands by filing date | |
| LUMINEX CORP | 55027E102 | COMMON STOCK | 68,131 | $1,788,000 | thousands by filing date | |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 52,131 | $1,740,000 | thousands by filing date | |
| ARCTURUS THERAPEUTICS HLDGS | 03969T109 | COM | 34,485 | $1,479,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 23,588 | $1,442,000 | thousands by filing date | |
| CORTEXYME INC | 22053A107 | COM | 21,827 | $1,091,000 | thousands by filing date | |
| BAXTER INTL INC | 071813109 | COM | 12,575 | $1,011,000 | thousands by filing date | |
| AXOGEN INC | 05463X106 | COM | 70,209 | $817,000 | thousands by filing date | |
| SENSEONICS HLDGS INC | 81727UAA3 | NOTE 5.250% 2/0 | 1,500,000 | $682,000 | thousands by filing date | |
| INHIBRX INC | 45720L107 | COM | 35,935 | $647,000 | thousands by filing date | |
| PENNANT GROUP INC | 70805E109 | COM | 13,699 | $528,000 | thousands by filing date | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 12,000 | $396,000 | thousands by filing date | |
| AILERON THERAPEUTICS INC COM NEW | 00887A105 | Stock | 263,439 | $340,000 | thousands by filing date | |
| CORBUS PHARMACEUTICALS HLDGS | 21833P103 | COM | 89,886 | $162,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001633055-20-000005 | this filing | 2020-11-16 | acceptance time not in the bulk data set |